abstract |
USE OF PB-10 COMPOUNDS 33 EFFECTIVE FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD), AS WELL AS THOSE COMPOUNDS. The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development or otherwise treating or ameliorating the symptoms of age-related macular degeneration (AMD) or related retinal conditions, in mammals, and particularly, in humans. The present invention further provides therapeutic compositions that allow dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions. |